Article
Symptomatic males and female carriers in a large Caucasian kindred with XIAP deficiency.
Journal of clinical immunology - 1 Jul 2015
Dziadzio Magdalena, Ammann Sandra, Canning Claire, Boyle Fiona, Hassan Amel, Cale Cathy, Elawad Mamoun, Fiil Berthe Katrine, Gyrd-Hansen Mads, Salzer Ulrich, Speckmann Carsten, Grimbacher Bodo
Abstract excerpt
PURPOSE: X-linked inhibitor of apoptosis (XIAP) deficiency caused by mutations in BIRC4 was originally described in male patients with X-linked lymphoproliferative syndrome type 2 (XLP2). Recent observations have highlighted a critical role of XIAP for the regulation of NOD2 signaling and are probably the molecular basis for increasingly recognized further immune dysregulatory symptoms of XIAP deficient patients,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
